Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-23-000268
Filing Date
2023-01-09
Accepted
2023-01-09 06:50:51
Documents
50
Period of Report
2023-01-09

Document Format Files

Seq Description Document Type Size
1 6-K phvs-6k_20230109.htm 6-K 19532
2 EX-99.1 phvs-ex991_6.htm EX-99.1 23573
3 EX-99.2 phvs-ex992_44.htm EX-99.2 41760
4 GRAPHIC slide-cn4r4y1ckhf.jpg GRAPHIC 302812
5 GRAPHIC slide-qc4d3szoz1d.jpg GRAPHIC 200283
6 GRAPHIC slide-1yr04nbcb11.jpg GRAPHIC 185125
7 GRAPHIC slide-qmyepjzljjv.jpg GRAPHIC 252347
8 GRAPHIC slide-of3jqml4tdq.jpg GRAPHIC 303224
9 GRAPHIC slide-21bdx43r4ac.jpg GRAPHIC 85108
10 GRAPHIC slide-c34oh1vsffo.jpg GRAPHIC 254882
11 GRAPHIC slide-zy35kieapsd.jpg GRAPHIC 281910
12 GRAPHIC slide-p1xkp4cg1jz.jpg GRAPHIC 184457
13 GRAPHIC slide-p2j5t5ifbg4.jpg GRAPHIC 193858
14 GRAPHIC slide-3rcdslwqag3.jpg GRAPHIC 181816
15 GRAPHIC slide-xyq1uigrijh.jpg GRAPHIC 224456
16 GRAPHIC slide-tdmnbnbblug.jpg GRAPHIC 296459
17 GRAPHIC slide-m0wsqscq341.jpg GRAPHIC 283602
18 GRAPHIC slide-vffduz1f5pa.jpg GRAPHIC 166764
19 GRAPHIC slide-xefrgigvcyy.jpg GRAPHIC 163569
20 GRAPHIC slide-103mvm0mdm2.jpg GRAPHIC 266635
21 GRAPHIC slide-c2px05xudzx.jpg GRAPHIC 237417
22 GRAPHIC g3djw0dgamrm000001.jpg GRAPHIC 35528
23 GRAPHIC slide-bh231ir2g3e.jpg GRAPHIC 241521
24 GRAPHIC slide-ialqxs2llbq.jpg GRAPHIC 172798
25 GRAPHIC slide-gnd0s0dmbyt.jpg GRAPHIC 163451
26 GRAPHIC slide-h0a534fmabe.jpg GRAPHIC 298514
27 GRAPHIC slide-azrbrqnz4xf.jpg GRAPHIC 168099
28 GRAPHIC slide-luicrr2r34u.jpg GRAPHIC 264659
29 GRAPHIC slide-aojegenbnro.jpg GRAPHIC 218223
30 GRAPHIC slide-wqa2talsb5d.jpg GRAPHIC 63371
31 GRAPHIC slide-ip0cvhd14bp.jpg GRAPHIC 190994
32 GRAPHIC slide-nkumdout1ma.jpg GRAPHIC 211555
33 GRAPHIC slide-0nmmqq1sub3.jpg GRAPHIC 257700
34 GRAPHIC slide-dcjdfy4ildv.jpg GRAPHIC 457316
35 GRAPHIC slide-oqngbeic4yx.jpg GRAPHIC 248252
36 GRAPHIC slide-hinqrsridt3.jpg GRAPHIC 183723
37 GRAPHIC slide-stch022tjke.jpg GRAPHIC 284705
38 GRAPHIC slide-nxpgx1hwlrh.jpg GRAPHIC 261128
39 GRAPHIC slide-ubecatyg42s.jpg GRAPHIC 193465
40 GRAPHIC slide-lusjou1j35i.jpg GRAPHIC 235949
41 GRAPHIC slide-bkg222iobfc.jpg GRAPHIC 272539
42 GRAPHIC slide-iiui41jioni.jpg GRAPHIC 87730
43 GRAPHIC slide-ijcqyretqff.jpg GRAPHIC 194341
44 GRAPHIC slide-v1gpbfrhlkp.jpg GRAPHIC 259945
45 GRAPHIC slide-j24egorwqxs.jpg GRAPHIC 204423
46 GRAPHIC slide-rkls1bgcde4.jpg GRAPHIC 210197
47 GRAPHIC slide-3tip4puysj3.jpg GRAPHIC 273533
48 GRAPHIC slide-qs2oh1kwh4m.jpg GRAPHIC 317539
49 GRAPHIC slide-3434d4f53xe.jpg GRAPHIC 223263
50 GRAPHIC slide-ju0wktrtdlm.jpg GRAPHIC 83909
  Complete submission text file 0001564590-23-000268.txt   14338525
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Filer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40010 | Film No.: 23516475
SIC: 2834 Pharmaceutical Preparations